Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Actinomycin Z1

0.0(0)
Write a reviewAsk a question

Application:
Actinomycin Z1 is a polypeptide antibiotic agent
Molecular Weight:
1301.41
Molecular Formula:
C62H84N12O19
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Actinomycin Z1 is a less commonly referenced member of the actinomycin family of compounds, which are chromopeptide lactones known primarily for their interaction with DNA. Like other actinomycins, Actinomycin Z1 functions by intercalating between specific guanine-cytosine base pairs within the DNA double helix. This intercalation disrupts the transcriptional processes by physically obstructing the progression of RNA polymerase along the DNA template, thereby inhibiting the synthesis of messenger RNA (mRNA). This specific action makes Actinomycin Z1 invaluable in molecular biology research, where it is used to explore the mechanisms of gene expression and the cellular responses to transcription inhibition. Research applications often include studying the transcriptional dynamics within cells, investigating the regulation of gene activity, and understanding how cells respond to genetic stress. Additionally, Actinomycin Z1′s ability to bind DNA makes it a useful tool for examining the structural and functional impacts of DNA-binding drugs on chromatin architecture and gene regulation. Through these research applications, Actinomycin Z1 provides insights into the fundamental processes that govern cellular function and genetic regulation, contributing to a broader understanding of cellular biology and genetics.


Actinomycin Z1 References

  1. Identification of actinomycins by high performance liquid chromatography and fast atom bombardment mass spectrometry.  |  Cho, S., et al. 1994. Arch Pharm Res. 17: 424-7. PMID: 10319152
  2. Computational exploration of natural peptides targeting ACE2.  |  He, M., et al. 2022. J Biomol Struct Dyn. 40: 8018-8029. PMID: 33826484
  3. Isolation and characterization of bulgecins, new bacterial metabolites with bulge-inducing activity.  |  Shinagawa, S., et al. 1985. J Antibiot (Tokyo). 38: 17-23. PMID: 3918981
  4. Studies on the biological activities of actinomycins Z1 and Z5.  |  Mason, K., et al. 1974. Arch Biochem Biophys. 160: 402-11. PMID: 4133977
  5. The presence of alpha-amino-beta, gamma-dihydroxybutyric acid in hydrolysates of actinomycin Z1.  |  Katz, E., et al. 1974. J Antibiot (Tokyo). 27: 952-15. PMID: 4143203
  6. 3-hydroxy-5-methylproline, a new amino acid identified as a component of actinomycin Z1.  |  Katz, E., et al. 1975. Biochem Biophys Res Commun. 63: 502-8. PMID: 47746
  7. Novel actinomycins formed by biosynthetic incorporation of cis- and trans-4-methylproline.  |  Katz, E., et al. 1977. Antimicrob Agents Chemother. 11: 1056-63. PMID: 69418
  8. Diastereoselective syntheses of (2R, 3R, 5R)-and (2S, 3S, 5S)-3-hydroxy-5-methyl-2-pyrrolidinecarboxylic acid as a component of actinomycin Z1  |  Tanaka, K. I. and Sawanishi, H. 1998. Tetrahedron. 54(34): 10029-10042.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Actinomycin Z1, 200 µg

sc-205926
200 µg
$70.00